Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Income Statement [Abstract] | ||
| Revenues | $ 112 | |
| Cost of revenues | (105) | |
| Gross profit | 7 | |
| Research and development expenses | (75) | |
| General and administrative expenses (Note 10) | (1,305) | (961) |
| Operating loss | (1,305) | (1,029) |
| Financing expenses, net | (63) | (82) |
| Net loss | $ (1,368) | $ (1,111) |
| Loss per share (basic and diluted) (Note 12) | $ (0.04) | $ (0.04) |
| Basic and diluted weighted average number of shares of Common Stock outstanding | 37,285,015 | 25,027,075 |